National Cancer Institute, Research Contracts Branch, PCCS, 6120 Executive Blvd, Room 635, Bethesda, MD 20892-7226

A -- PHASE II SAFETY AND EFFICACY STUDY OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 OR NSAID IN HPNCC PATIENTS AND CARRIERS, WORKSTATEMENT NO. 49 POC Susan K. Hoffman, Contracting Officer, 301/435-3799 CNT N01-CN-75021-MAO AMT $1,525,403 DTD 043097 TO The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030 E-MAIL: Susan K. Hoffman, hoffmans@rcb.nci.nih.gov. (0118)

Loren Data Corp. http://www.ld.com (SYN# 0332 19970430\A-0012.AWD)